research use only

BIBF 1120 (Nintedanib) PDGFR/VEGFR inhibitor

Cat.No.S1010

Nintedanib is a potent triple angiokinase inhibitor for VEGFR1/2/3, FGFR1/2/3 and PDGFRα/β with IC50 of 34 nM/13 nM/13 nM, 69 nM/37 nM/108 nM and 59 nM/65 nM in cell-free assays. Phase 3.
Jump to

Quality Control

Batch: Purity: 99.98%
99.98

Solubility in DMSO or Water

In vitro
Batch:

DMSO : 10 mg/mL (18.53 mM)
(Moisture-contaminated DMSO may reduce solubility. Use fresh, anhydrous DMSO.)

Water : Insoluble

Ethanol : Insoluble

The solubility data above are all experimental results (not literature values).

Molarity Calculator

Mass Concentration Volume Molecular Weight
Dilution Calculator Molecular Weight Calculator

In vivo
Batch:

In vivo Formulation Calculator (Clear solution)

Step 1: Enter information below (Recommended: An additional animal making an allowance for loss during the experiment)

mg/kg
g
μL

Step 2: Enter the in vivo formulation (This is only the calculator, not formulation. Please contact us first if there is no in vivo formulation at the solubility Section.)

% DMSO
%
% Tween 80
% ddH2O
% DMSO
+
%

Calculation results:

Working concentration: mg/ml;

Method for preparing DMSO master liquid: mg drug pre-dissolved in μL DMSO ( Master liquid concentration mg/mL, Please contact us first if the concentration exceeds the DMSO solubility of the batch of drug. )

Method for preparing in vivo formulation: Take μL DMSO master liquid, next addμL PEG300, mix and clarify, next addμL Tween 80, mix and clarify, next add μL ddH2O, mix and clarify.

Method for preparing in vivo formulation: Take μL DMSO master liquid, next add μL Corn oil, mix and clarify.

Note: 1. Please make sure the liquid is clear before adding the next solvent.
2. Be sure to add the solvent(s) in order. You must ensure that the solution obtained, in the previous addition, is a clear solution before proceeding to add the next solvent. Physical methods such
as vortex, ultrasound or hot water bath can be used to aid dissolving.

Read more about BIBF 1120 (Nintedanib) solubility in DMSO or water

Working Concentrations for Cell Culture Treatment

Step 1: Select a research area to find working concentrations, or search directly for a cell line

Read more about BIBF 1120 (Nintedanib) working concentrations for cell culture treatment

Working Concentrations for Animal Model Treatment

Step 1: Select a research area to find working concentrations, or search directly for an animal type

×

Mechanism of Action

Information BIBF 1120 (Nintedanib) is a potent, ATP-competitive VEGFR, FGFR, and PDGFR inhibitor. It affects VEGF, FGF, and PDGF signaling, by binding to the kinase ATP-binding clefts, inhibiting angiogenesis, tumor growth, and pulmonary fibrosis.

Read more about BIBF 1120 (Nintedanib) IC50 for cell-based and cell-free assays

Primary Applications and Mechanism of Action

Read more about BIBF 1120 (Nintedanib) Mechanism of Action

Chemical Information, Storage & Stability

Molecular Weight 539.62 Formula

C31H33N5O4

Storage (From the date of receipt)
CAS No. 656247-17-5 Download SDF Storage of Stock Solutions

Synonyms BIBF 1120, Intedanib Smiles CN1CCN(CC1)CC(=O)N(C)C2=CC=C(C=C2)N=C(C3=CC=CC=C3)C4=C(NC5=C4C=CC(=C5)C(=O)OC)O

Read more about storage & stability

Please select the combination compounds (Multiple selections allowed)
Please select a combination compound first

Read more comparative analysis about BIBF 1120 (Nintedanib)

Tech Support

Handling Instructions

Tel: +1-832-582-8158 Ext:3

If you have any other enquiries, please leave a message.